Table 1: Demographics.
N |
12 |
% Female |
92% |
Age (mean, years) |
61.6 +/-12.2 |
Race |
|
White n (%) |
10 (83%) |
Hispanic/Latino n (%) |
0 |
Asian n (%) |
2 (17%) |
Black/African American n (%) |
0 |
BMI (kg/m2) |
21.6 +/-3.3 |
Tobacco use history |
|
Never smoker n (%) |
10 (83%) |
Former smoker n (%) |
2 (17%) |
Average pack years (years) |
15 |
Co-morbidities |
|
Asthma n (%) |
3 (25%) |
COPD n (%) |
0 |
Immunocompromised n (%) |
1 (8.3%) |
Rheumatologic disease n (%) |
1 (8.3%) |
GERD n (%) |
7 (58%) |
Diabetes n (%) |
0 |
HTN n (%) |
3 (25%) |
Pre-operative PFTs |
|
FEV1/FVC% predicted |
74% |
FEV1 L (% predicted) |
2.22 L (83.4 %) |
FVC L (% predicted) |
2.98 L (90.1%) |
DLCO % predicted |
81% |
Indication for surgery |
|
Failure of medical therapy n (%) |
3 (25%) |
Cavitary disease n (%) |
7 (58%) |
Hemoptysis n (%) |
2 (16%) |
NTM species |
|
MAI n (%) |
12 (100%) |
M abscessus n (%) |
0 |
M xenopi n (%) |
0 |
NTM-LD: Non-tuberculous mycobacterial lung disease; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease; GERD: Gastroesophageal reflux disease; HTN: Hypertension; FEV1: Forced expiratory volume in 1 second; FVC: Forced vital capacity; DLCO: Diffusing capacity of the lungs for carbon monoxide; NTM: Non-tuberculous mycobacteria; MAI: Mycobacterium avium intracellulare; M abscessus: Mycobacterium abscessus; M xenopi: Mycobacterium xenopi